Activated PI3Kδ breaches multiple B cell tolerance checkpoints and causes autoantibody production
暂无分享,去创建一个
L. Notarangelo | S. Choo | Joanne M. Smart | S. Tangye | C. Goodnow | G. Uzel | E. Deenick | R. Brink | J. Reed | I. Meyts | D. Avery | M. Wong | K. Boztug | S. Volpi | A. Russell | Katherine J. L. Jackson | T. Cole | P. Gray | P. Hsu | L. Berglund | Julia Bier | Michael O’Sullivan | A. Lau | Helen Lenthall | Katherine J L Jackson | Henry Brigden
[1] L. Notarangelo,et al. Activating mutations in PIK3CD disrupt the differentiation and function of human and murine CD4+ T cells. , 2019, The Journal of allergy and clinical immunology.
[2] M. Reth,et al. Pten controls B‐cell responsiveness and germinal center reaction by regulating the expression of IgD BCR , 2019, The EMBO journal.
[3] R. Pelanda,et al. Active PI3K abrogates central tolerance in high-avidity autoreactive B cells , 2019, The Journal of experimental medicine.
[4] V. Sarapura,et al. Elevated PTEN expression maintains anergy in human B cells and reveals unexpectedly high repertoire autoreactivity. , 2019, JCI insight.
[5] J. Cannons,et al. PI3K Orchestrates T Follicular Helper Cell Differentiation in a Context Dependent Manner: Implications for Autoimmunity , 2019, Front. Immunol..
[6] S. Choo,et al. Activating PIK3CD mutations impair human cytotoxic lymphocyte differentiation and function and EBV immunity , 2019, The Journal of allergy and clinical immunology.
[7] Genita Metzler,et al. Activated PIK3CD drives innate B cell expansion yet limits B cell–intrinsic immune responses , 2018, The Journal of experimental medicine.
[8] C. Goodnow,et al. Molecular Profiling and Clonal Tracking of Secreted Rheumatoid Factors in Primary Sjögren's Syndrome , 2018, Arthritis & rheumatology.
[9] G. Uzel,et al. Genetic Defects in Phosphoinositide 3-Kinase δ Influence CD8+ T Cell Survival, Differentiation, and Function , 2018, Front. Immunol..
[10] Ivan K. Chinn,et al. Mutations in PI3K110&dgr; cause impaired natural killer cell function partially rescued by rapamycin treatment , 2018, The Journal of allergy and clinical immunology.
[11] Andrea J. Radtke,et al. Hyperactivated PI3Kδ promotes self and commensal reactivity at the expense of optimal humoral immunity , 2018, Nature Immunology.
[12] W. Shi,et al. Germline-activating mutations in PIK3CD compromise B cell development and function , 2018, The Journal of experimental medicine.
[13] K. Schwarz,et al. CD57 identifies T cells with functional senescence before terminal differentiation and relative telomere shortening in patients with activated PI3 kinase delta syndrome , 2018, Immunology and cell biology.
[14] T. Phan,et al. Self-Reactive B Cells in the Germinal Center Reaction. , 2018, Annual review of immunology.
[15] Benjamin T. Porebski,et al. Germinal center antibody mutation trajectories are determined by rapid self/foreign discrimination , 2018, Science.
[16] K. Okkenhaug,et al. PI3Kδ hyper-activation promotes development of B cells that exacerbate Streptococcus pneumoniae infection in an antibody-independent manner , 2018, bioRxiv.
[17] A. Fischer,et al. Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome Registry , 2018, Front. Immunol..
[18] M. van der Burg,et al. Exhaustion of the CD8+ T Cell Compartment in Patients with Mutations in Phosphoinositide 3-Kinase Delta , 2018, Front. Immunol..
[19] B. Sloth,et al. Effective "activated PI3Kδ syndrome"-targeted therapy with the PI3Kδ inhibitor leniolisib. , 2017, Blood.
[20] Lewis C. Cantley,et al. The PI3K Pathway in Human Disease , 2017, Cell.
[21] J. Casanova,et al. Self-reactive VH4-34–expressing IgG B cells recognize commensal bacteria , 2017, The Journal of experimental medicine.
[22] David Nemazee,et al. Mechanisms of central tolerance for B cells , 2017, Nature Reviews Immunology.
[23] M. van der Burg,et al. Genetic defects in PI3Kδ affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections. , 2017, Clinical immunology.
[24] Bodo Grimbacher,et al. Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study , 2017, The Journal of allergy and clinical immunology.
[25] M. Shlomchik,et al. Continuous inhibitory signaling by both SHP-1 and SHIP-1 pathways is required to maintain unresponsiveness of anergic B cells , 2016, The Journal of experimental medicine.
[26] D. Uprety,et al. Idelalisib- a PI3Kδ targeting agent for B-cell malignancies , 2016, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
[27] J. Cambier,et al. B cell expression of the SH2-containing inositol 5-phosphatase (SHIP-1) is required to establish anergy to high affinity, proteinacious autoantigens. , 2015, Journal of autoimmunity.
[28] A. Strasser,et al. FAS Inactivation Releases Unconventional Germinal Center B Cells that Escape Antigen Control and Drive IgE and Autoantibody Production. , 2015, Immunity.
[29] Patrice Duroux,et al. IMGT®, the international ImMunoGeneTics information system® 25 years on , 2014, Nucleic Acids Res..
[30] S. Pittaluga,et al. Mutations in PIK3CD Can Cause Hyper IgM Syndrome (HIGM) Associated with Increased Cancer Susceptibility , 2014, Journal of Clinical Immunology.
[31] Nada Jabado,et al. Phosphoinositide 3-Kinase δ Gene Mutation Predisposes to Respiratory Infection and Airway Damage , 2013, Science.
[32] J. B. Oliveira,et al. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency , 2013, Nature Immunology.
[33] Ning Ma,et al. IgBLAST: an immunoglobulin variable domain sequence analysis tool , 2013, Nucleic Acids Res..
[34] K. Okkenhaug. Signaling by the phosphoinositide 3-kinase family in immune cells. , 2013, Annual review of immunology.
[35] M. Camilleri,et al. Pemphigus Vulgaris Autoantibody Profiling by Proteomic Technique , 2013, PloS one.
[36] H. Kole,et al. Aberrant antibody affinity selection in SHIP‐deficient B cells , 2013, European journal of immunology.
[37] R. Brink,et al. Elimination of germinal-center-derived self-reactive B cells is governed by the location and concentration of self-antigen. , 2012, Immunity.
[38] Zhengwei Zhu,et al. CD-HIT: accelerated for clustering the next-generation sequencing data , 2012, Bioinform..
[39] M. Cook,et al. Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. , 2012, Autoimmunity reviews.
[40] Idan Tamir,et al. Monophosphorylation of CD79a and CD79b ITAM motifs initiates a SHIP-1 phosphatase-mediated inhibitory signaling cascade required for B cell anergy. , 2011, Immunity.
[41] S. Salzberg,et al. FLASH: fast length adjustment of short reads to improve genome assemblies , 2011, Bioinform..
[42] R. Rickert,et al. Suppression of phosphatidylinositol 3,4,5-trisphosphate production is a key determinant of B cell anergy. , 2009, Immunity.
[43] M. Gold,et al. Phosphoinositide 3-Kinase p110δ Regulates Natural Antibody Production, Marginal Zone and B-1 B Cell Function, and Autoantibody Responses1 , 2009, The Journal of Immunology.
[44] R. DePinho,et al. PI3 Kinase Signals BCR-Dependent Mature B Cell Survival , 2009, Cell.
[45] M. Shlomchik,et al. Sites and stages of autoreactive B cell activation and regulation. , 2008, Immunity.
[46] J. Leignadier,et al. IL‐21 promotes T lymphocyte survival by activating the phosphatidylinositol‐3 kinase signaling cascade , 2007, Journal of leukocyte biology.
[47] D. Levy,et al. The molecular basis of IL-21-mediated proliferation. , 2007, Blood.
[48] N. Olsen,et al. Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes , 2006, Clinical and experimental immunology.
[49] T. Phan,et al. High affinity germinal center B cells are actively selected into the plasma cell compartment , 2006, The Journal of experimental medicine.
[50] T. Phan,et al. Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation , 2006, The Journal of experimental medicine.
[51] K. Sundar,et al. Loss of tolerance of anti-dsDNA B cells in mice overexpressing CD19. , 2006, Molecular immunology.
[52] C. Goodnow,et al. Cellular and genetic mechanisms of self tolerance and autoimmunity , 2005, Nature.
[53] A. Cappione,et al. Lupus IgG VH4.34 Antibodies Bind to a 220-kDa Glycoform of CD45/B220 on the Surface of Human B Lymphocytes1 , 2004, The Journal of Immunology.
[54] M. Nussenzweig,et al. Predominant Autoantibody Production by Early Human B Cell Precursors , 2003, Science.
[55] Jhagvaral Hasbold,et al. B Cell Receptor–independent Stimuli Trigger Immunoglobulin (Ig) Class Switch Recombination and Production of IgG Autoantibodies by Anergic Self-Reactive B Cells , 2003, The Journal of experimental medicine.
[56] A I Saeed,et al. TM4: a free, open-source system for microarray data management and analysis. , 2003, BioTechniques.
[57] T. Fleisher,et al. Human B cells express a CD45 isoform that is similar to murine B220 and is downregulated with acquisition of the memory B‐cell marker CD27 , 2003, Cytometry. Part B, Clinical cytometry.
[58] A. Cappione,et al. Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. , 2001, The Journal of clinical investigation.
[59] P. Pandolfi,et al. Impaired Fas response and autoimmunity in Pten+/- mice. , 1999, Science.
[60] C. Goodnow,et al. CD19-Regulated Signaling Thresholds Control Peripheral Tolerance and Autoantibody Production in B Lymphocytes , 1997, The Journal of experimental medicine.
[61] P. Hodgkin,et al. Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[62] P. Linsley,et al. Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells , 1994, The Journal of experimental medicine.
[63] R. Geha,et al. Signal transduction via CD40 involves activation of lyn kinase and phosphatidylinositol-3-kinase, and phosphorylation of phospholipase C gamma 2 , 1994, The Journal of experimental medicine.
[64] V. Pascual,et al. Molecular characterization of a cross-reactive idiotope on human immunoglobulins utilizing the VH4-21 gene segment , 1993, The Journal of experimental medicine.
[65] S. Smith‐Gill,et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice , 1988, Nature.
[66] T. Phan,et al. The SW(HEL) system for high-resolution analysis of in vivo antigen-specific T-dependent B cell responses. , 2015, Methods in molecular biology.
[67] Peter J. Schaap,et al. Molecular characterization of the , 1997 .